| Literature DB >> 28979690 |
Renjin Lin1,2, Huanwen Chen3, Daniel Callow4, Shihen Li1,2, Lei Wang2, Shi Li1,2, Long Chen1,2, Jian Ding1,2, Weiyang Gao1,2, Huazi Xu1,2, Jianzhong Kong1,2, Kailiang Zhou1,2.
Abstract
Random pattern skin flap transplantation is frequently applied in plastic and reconstructive surgery, but the distal part of skin flaps often suffers necrosis due to ischemia. Astragaloside IV (AS-IV), a natural saponin purified from Astragalus membranaceus, may have beneficial functions for flap survival. In this study, rats were divided into a control group and an AS-IV treatment group, and underwent surgery using a modified "McFarlane flap" model. After intragastric administration of vehicle control or AS-IV for their respective groups, flap survival area and water content were measured 7 days after surgery. Flap tissue was separated to test protein expressions related to angiogenesis, inflammation, oxidative stress and autophagy via western blot, immunohistochemistry, and immunofluorescence. Results showed that AS-IV improved flap survival area and reduced tissue edema. AS-IV also increased mean vessel densities and upregulated levels of VEGF protein, both of which indicate increased angiogenesis. Furthermore, AS-IV depressed leukocyte infiltration, decreased expressions of inflammatory proteins TNF-α, IL1β and IL6, increased SOD activity, decreased MDA content, and stimulated autophagy. Overall, our results suggest that AS-IV promotes skin flap survival via inducing angiogenesis, depressing inflammation and dampening oxidative stress; it also activates autophagy, which may be an underlying mechanism for oxidative stress depression.Entities:
Keywords: Astragaloside IV; angiogenesis; autophagy; inflammation; oxidative stress; random skin flap survival
Year: 2017 PMID: 28979690 PMCID: PMC5622259
Source DB: PubMed Journal: Am J Transl Res ISSN: 1943-8141 Impact factor: 4.060